Wellington Partners

Wellington Partners is a prominent European venture capital firm headquartered in Munich, Germany, specializing in early-stage investments across two distinct sectors: Life Sciences and Digital. The firm has established itself as a key player in the German and broader European startup ecosystem, providing capital and strategic support to innovative companies. Their investment thesis centers on identifying disruptive technologies and business models with high growth potential, aiming to be a long-term partner for their portfolio companies.

In the Life Sciences sector, Wellington Partners targets companies involved in biotechnology, pharmaceuticals, medical devices, diagnostics, and digital health solutions. Their Digital portfolio encompasses a wide array of technologies, including software, internet, mobile applications, e-commerce, fintech, artificial intelligence, and SaaS platforms. The firm's approach involves not just capital infusion but also active engagement with portfolio companies, leveraging their extensive network and operational expertise to foster growth and market expansion.

Wellington Partners manages substantial capital across its dedicated funds. For instance, their Wellington Partners V fund, focused on digital investments, closed at €100 million, while the Wellington Partners Life Sciences V fund successfully raised €210 million. These dedicated funds underscore their specialized focus and capacity to support companies within their respective domains. Initial investments typically range from €0.5 million to €5 million, reflecting their commitment to early-stage funding and their strategy to participate in follow-on rounds as their portfolio companies mature.